Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2020 Filed Feb 24, 2020 21:12 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007183 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Ordinary Shares · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:12 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 2,016 | $20.24 | $40,803.84 |
DisclosureSEC source: 0001127602-20-007183 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,346 Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:12 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 6,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007183 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:10 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 4,800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007179 · form4.xml · derivative · entry 5 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,400 Underlying: Ordinary Shares · 4,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:10 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Tax withholdingOrdinary Shares | 1,391 | $20.24 | $28,153.84 |
DisclosureSEC source: 0001127602-20-007179 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,993 Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:10 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionOrdinary Shares | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007179 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Jan 15, 2021 21:37 UTC Amendment |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001769 · form4a.xml · derivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,625 Underlying: Ordinary Shares · 6,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Table II of the Form 4 filed on February 24, 2020 inadvertently reported an exercise by the reporting person of an employee stock option in lieu of reporting the vesting of a restricted stock unit award.??This amendment is being filed to correct Table II to show the vesting of such restricted stock unit award.??All other information reported in the original Form 4 remains the same. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020. Read SEC document |
| February 21, 2020 Filed Jan 15, 2021 21:37 UTC Amendment |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 6,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001769 · form4a.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:15 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 358,466 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001127602-20-007190 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,466 Underlying: Ordinary Shares · 358,466 shares Expires 2030-02-20 F1 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 16:14 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 21,415 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007186 · form4.xml · derivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,415 Underlying: Ordinary Shares · 21,415 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 16:14 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 89,545 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001127602-20-007186 · form4.xml · derivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,545 Underlying: Ordinary Shares · 89,545 shares Expires 2030-02-20 F1 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:11 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
GrantRestricted Stock Unit Award · Derivative | 24,474 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007180 · form4.xml · derivative · entry 7 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,474 Underlying: Ordinary Shares · 24,474 shares Expires not disclosed F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:11 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 102,337 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001127602-20-007180 · form4.xml · derivative · entry 6 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,337 Underlying: Ordinary Shares · 102,337 shares Expires 2030-02-20 F3 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:13 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantRestricted Stock Unit Award · Derivative | 40,382 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007184 · form4.xml · derivative · entry 4 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,382 Underlying: Ordinary Shares · 40,382 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:13 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 168,856 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001127602-20-007184 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,856 Underlying: Ordinary Shares · 168,856 shares Expires 2030-02-20 F1 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:12 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 28,145 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007183 · form4.xml · derivative · entry 4 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,145 Underlying: Ordinary Shares · 28,145 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:12 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 117,688 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001127602-20-007183 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,688 Underlying: Ordinary Shares · 117,688 shares Expires 2030-02-20 F1 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:10 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
GrantRestricted Stock Unit Award · Derivative | 18,356 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007179 · form4.xml · derivative · entry 4 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,356 Underlying: Ordinary Shares · 18,356 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:10 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 76,753 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001127602-20-007179 · form4.xml · derivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,753 Underlying: Ordinary Shares · 76,753 shares Expires 2030-02-20 F1 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/20/2021. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:12 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · derivative · entry 6 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Ordinary Shares · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:12 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Tax withholdingOrdinary Shares | 3,886 | $17.77 | $69,054.22 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 731,350 Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:12 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 16:11 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006021 · form4.xml · derivative · entry 4 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Ordinary Shares · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 16:11 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006021 · form4.xml · nonDerivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:07 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006015 · form4.xml · derivative · entry 9 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Ordinary Shares · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:07 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Tax withholdingOrdinary Shares | 904 | $17.77 | $16,064.08 |
DisclosureSEC source: 0001127602-20-006015 · form4.xml · nonDerivative · entry 4 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,555 Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:07 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionOrdinary Shares | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006015 · form4.xml · nonDerivative · entry 3 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:09 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006019 · form4.xml · derivative · entry 6 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:09 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 766 | $17.77 | $13,611.82 |
DisclosureSEC source: 0001127602-20-006019 · form4.xml · nonDerivative · entry 4 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,487 Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:09 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006019 · form4.xml · nonDerivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:05 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006009 · form4.xml · derivative · entry 6 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Ordinary Shares · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:05 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Tax withholdingOrdinary Shares | 868 | $17.77 | $15,424.36 |
DisclosureSEC source: 0001127602-20-006009 · form4.xml · nonDerivative · entry 4 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,584 Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:05 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionOrdinary Shares | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006009 · form4.xml · nonDerivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:12 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 18,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · derivative · entry 5 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Ordinary Shares · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:12 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Tax withholdingOrdinary Shares | 8,072 | $17.77 | $143,439.44 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 726,486 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:12 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
Exercise / conversionOrdinary Shares | 18,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 734,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 16:11 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006021 · form4.xml · derivative · entry 3 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Underlying: Ordinary Shares · 3,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 16:11 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006021 · form4.xml · nonDerivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:07 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006015 · form4.xml · derivative · entry 8 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Underlying: Ordinary Shares · 3,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:07 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Tax withholdingOrdinary Shares | 1,172 | $17.77 | $20,826.44 |
DisclosureSEC source: 0001127602-20-006015 · form4.xml · nonDerivative · entry 2 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,459 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:07 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionOrdinary Shares | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006015 · form4.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:09 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006019 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Underlying: Ordinary Shares · 3,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:09 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 1,172 | $17.77 | $20,826.44 |
DisclosureSEC source: 0001127602-20-006019 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,753 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:09 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006019 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:10 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006020 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Underlying: Ordinary Shares · 3,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:10 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 1,172 | $17.77 | $20,826.44 |
DisclosureSEC source: 0001127602-20-006020 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,080 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:10 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006020 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:05 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006009 · form4.xml · derivative · entry 5 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,750 Underlying: Ordinary Shares · 2,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:05 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Tax withholdingOrdinary Shares | 825 | $17.77 | $14,660.25 |
DisclosureSEC source: 0001127602-20-006009 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,952 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:05 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionOrdinary Shares | 2,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006009 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.